D'ADDIO, FRANCESCA
 Distribuzione geografica
Continente #
EU - Europa 7.224
NA - Nord America 3.935
AS - Asia 3.093
SA - Sud America 522
AF - Africa 119
OC - Oceania 63
Continente sconosciuto - Info sul continente non disponibili 2
Totale 14.958
Nazione #
US - Stati Uniti d'America 3.595
IT - Italia 3.011
GB - Regno Unito 1.570
CN - Cina 1.024
DE - Germania 796
SG - Singapore 544
SE - Svezia 436
IN - India 310
BR - Brasile 309
RU - Federazione Russa 189
FR - Francia 176
CA - Canada 175
JP - Giappone 174
ID - Indonesia 171
FI - Finlandia 141
HK - Hong Kong 138
IE - Irlanda 137
ES - Italia 133
TR - Turchia 127
MX - Messico 124
SA - Arabia Saudita 114
NL - Olanda 106
DK - Danimarca 101
TW - Taiwan 78
PT - Portogallo 77
VN - Vietnam 74
CO - Colombia 68
KR - Corea 67
PL - Polonia 61
TH - Thailandia 54
AU - Australia 53
CH - Svizzera 48
AT - Austria 47
EC - Ecuador 44
CL - Cile 38
EG - Egitto 38
PH - Filippine 38
BE - Belgio 34
GR - Grecia 34
PK - Pakistan 32
UA - Ucraina 30
PE - Perù 28
IR - Iran 27
RO - Romania 24
AE - Emirati Arabi Uniti 21
AR - Argentina 18
ZA - Sudafrica 18
HR - Croazia 13
LY - Libia 13
JO - Giordania 11
NG - Nigeria 10
NZ - Nuova Zelanda 10
PY - Paraguay 10
IQ - Iraq 9
MY - Malesia 9
GT - Guatemala 8
LB - Libano 8
MA - Marocco 8
NO - Norvegia 8
SV - El Salvador 8
BD - Bangladesh 7
CR - Costa Rica 7
CZ - Repubblica Ceca 7
DZ - Algeria 7
HU - Ungheria 7
IL - Israele 7
NP - Nepal 7
QA - Qatar 7
SC - Seychelles 7
SK - Slovacchia (Repubblica Slovacca) 7
UZ - Uzbekistan 7
KE - Kenya 6
RS - Serbia 6
VE - Venezuela 6
EE - Estonia 5
PS - Palestinian Territory 5
BA - Bosnia-Erzegovina 4
ET - Etiopia 4
KW - Kuwait 4
PA - Panama 4
PR - Porto Rico 4
AL - Albania 3
BH - Bahrain 3
DO - Repubblica Dominicana 3
LT - Lituania 3
ME - Montenegro 3
NI - Nicaragua 3
OM - Oman 3
TN - Tunisia 3
CU - Cuba 2
GE - Georgia 2
HN - Honduras 2
JE - Jersey 2
KZ - Kazakistan 2
ML - Mali 2
MM - Myanmar 2
SY - Repubblica araba siriana 2
ZM - Zambia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
Totale 14.946
Città #
Southend 1.430
Milan 618
Singapore 355
Chandler 328
Hanover 291
Fairfield 233
Ashburn 157
Seattle 155
Wilmington 152
Dublin 136
Beijing 135
Princeton 134
Ann Arbor 132
Council Bluffs 120
Woodbridge 112
Munich 109
New York 105
Houston 102
Dearborn 101
Helsinki 98
Cambridge 93
Istanbul 76
Santa Clara 76
Jakarta 75
Riyadh 75
Toronto 75
Bodio Lomnago 72
Nanjing 68
Frankfurt am Main 66
Hong Kong 64
Boardman 61
Rome 61
Bengaluru 58
Shanghai 58
Des Moines 57
Turin 56
Guangzhou 50
Tokyo 49
Phoenix 42
Redwood City 40
Shenyang 36
Berlin 35
São Paulo 35
Bogotá 33
Roxbury 33
Vienna 32
Dong Ket 31
Madison 31
Nuremberg 31
Central 30
Chicago 29
Madrid 29
Amsterdam 28
Changsha 28
Jinan 28
Santiago 27
Hyderabad 26
Mumbai 26
Los Angeles 25
Barcelona 24
Bühl 24
Bangkok 23
London 23
Chennai 22
Taipei 22
Jeddah 21
Lisbon 21
Wuhan 21
Fremont 20
Warsaw 20
Atlanta 19
Lima 19
San Diego 19
Brussels 18
Cairo 18
Shenzhen 18
Delhi 17
Guwahati 17
Hefei 17
Seoul 17
Boston 16
Buffalo 16
Cuenca 16
Rio de Janeiro 16
Sydney 16
Athens 15
Mexico City 15
Nanchang 15
Naples 15
Osaka 15
Florence 14
Genoa 14
Ho Chi Minh City 14
Medellín 14
Silver Spring 14
Amadora 13
Bologna 13
Grafing 13
Hangzhou 13
Hebei 13
Totale 7.558
Nome #
Anti-diabetic drugs and weight loss in patients with type 2 diabetes 3.452
Anti-inflammatory effects of diet and caloric restriction in metabolic syndrome 677
Indirect and Direct Effects of SARS-CoV-2 on Human Pancreatic Islets 494
The IGFBP3/TMEM219 pathway regulates beta cell homeostasis 489
Strictureplasties performed by laparoscopic approach for complicated Crohn's disease. A prospective, observational, cohort study 448
miR-21 antagonism reprograms macrophage metabolism and abrogates chronic allograft vasculopathy 420
Next-gen therapeutics to spare and expand beta-cell mass 387
Islet-Derived eATP Fuels Autoreactive CD8+ Cells and Facilitates the Onset of Type 1 Diabetes 267
Immunogenicity and safety of SARS-CoV-2 mRNA vaccines in a cohort of patients with type 1 diabetes 262
Metabolomic profiling in individuals with a failing kidney allograft 251
Prostaglandin E2 stimulates the expansion of regulatory hematopoietic stem and progenitor cells in type 1 diabetes 250
P2X7R mutation disrupts the NLRP3-mediated Th program and predicts poor cardiac allograft outcomes 246
HEBE project: Healthy aging versus inflamm-aging: The role of physical exercise in modulating the biomarkers of age-associated and environmentally determined chronic diseases, study protocol 219
Placental proteome abnormalities in women with gestational diabetes and large-for-gestational-age newborns 214
Long-term heart transplant survival by targeting the ionotropic purinergic receptor P2X7 210
Continuous glucose monitoring in patients with type 2 diabetes on hemodialysis 203
CD160Ig Fusion Protein Targets a Novel Costimulatory Pathway and Prolongs Allograft Survival 188
A novel role of CD4 Th17 cells in mediating cardiac allograft rejection and vasculopathy 180
Type 2 diabetes mellitus pharmacological remission with dapagliflozin plus oral semaglutide 177
Weight Loss Improves Cardio-Metabolic and Inflammatory State in Subjects with Metabolic Syndrome 160
Interleukin-10+ regulatory b cells arise within antigen-experienced CD40+ B cells to maintain tolerance to islet autoantigens 155
Weight loss improves cardio-metabolic and inflammatory state in subjects with metabolic syndrome 155
Embryonic stem cell extracts improve wound healing in diabetic mice 155
Positive effects of a novel non-peptidyl low molecular weight radical scavenger in renal ischemia/reperfusion : a preliminary report 149
Role of podocyte B7-1 in diabetic nephropathy 148
Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection 144
Prolonged, Low-Dose Anti-Thymocyte Globulin, Combined with CTLA4-Ig, Promotes Engraftment in a Stringent Transplant Model 143
Embryonic Cell Extracts Ameliorate Wound Healing in Diabetic Mice 143
Sitagliptin Treatment at the Time of Hospitalization Was Associated With Reduced Mortality in Patients With Type 2 Diabetes and COVID-19: A Multicenter, Case-Control, Retrospective, Observational Study 140
PD-1 blockade counteracts post-COVID-19 immune abnormalities and stimulates the anti-SARS-CoV-2 immune response 140
The β-cell effect of verapamil-based treatment in patients with type 2 diabetes: a systematic review 135
The IL-8-CXCR1/2 axis contributes to diabetic kidney disease 134
Effect of the purinergic inhibitor oxidized ATP in a model of islet allograft rejection 128
PD-L1 genetic overexpression or pharmacological restoration in hematopoietic stem and progenitor cells reverses autoimmune diabetes 126
Circulating IGF-I and IGFBP3 Levels Control Human Colonic Stem Cell Function and Are Disrupted in Diabetic Enteropathy 125
Immunoevasion rather than intrinsic oncogenicity may confer MSCs from non-obese diabetic mice the ability to generate neural tumors 124
The anti-inflammatory and immunological properties of GLP-1 Receptor Agonists 123
Effetto protettivo della restrizione calorica nella sindrome metabolica: miglioramento del profilo lipidomico e dell’attività anti-infiammatoria citochinica ed enzimatica (CETP) 121
Co-transplantation of autologous MSCs delays islet allograft rejection and generates a local immunoprivileged site 120
An in vivo autotransplant model of renal preservation : cold storage versus machine perfusion in the prevention of ischemia/reperfusion injury 116
The rise, fall, and resurgence of immunotherapy in type 1 diabetes 115
The use of hematopoietic stem cells in autoimmune diseases 114
Immunotherapy for type 1 diabetes 113
Hematopoietic Stem Cells in Type 1 Diabetes 112
Sodium glucose cotransporters inhibitors in type 1 diabetes 109
The impact of a successful treatment of hepatitis C virus on glyco-metabolic control in diabetic patients: a systematic review and meta-analysis 109
Islet transplantation stabilizes hemostatic abnormalities and cerebral metabolism in individuals with type 1 diabetes 107
Autologous nonmyeloablative hematopoietic stem cell transplantation in new-onset type 1 diabetes : a multicenter analysis 98
Harnessing the immunological properties of stem cells as a therapeutic option for diabetic nephropathy 97
5-Methyltetrahydrofolate administration is associated with prolonged survival and reduced inflammation in ESRD patients 95
Kidney-pancreas transplantation is associated with near-normal sexual function in uremic type 1 diabetic patients 94
B7h (ICOS-L) maintains tolerance at the fetomaternal interface 91
Regulatory B Cells in Autoimmune Diabetes 91
The link between the PDL1 costimulatory pathway and Th17 in fetomaternal tolerance 90
Combined Liver-Kidney Transplantation-S. Orsola Experience : Nephrological Aspects 89
A novel clinically relevant strategy to abrogate autoimmunity and regulate alloimmunity in NOD mice 88
Broadening horizons in mechanisms, management, and treatment of diabetic kidney disease 87
Abnormalities of the oculomotor function in type 1 diabetes and diabetic neuropathy 85
Targeting Tim-1 to overcome resistance to transplantation tolerance mediated by CD8 T17 cells 84
Trapianto renale e neoplasie maligne: esperienza a lungo termine (25 anni) di un singolo centro = Renal transplantation and malignancies: A single-centre experience (25 years) 83
Prevalence and significance of mesentery thickening and lymph nodes enlargement in Crohn's disease 82
Metabolic and immunological features of the failing islet-transplanted patient 81
Novel Soluble Mediators of Innate Immune System Activation in Solid Allograft Rejection 81
TIM4 regulates the anti-islet Th2 alloimmune response 80
Standard heparin versus low-molecular-weight heparin : a medium-term comparison in hemodialysis 78
Targeting the CXCR4-CXCL12 axis mobilizes autologous hematopoietic stem cells and prolongs islet allograft survival via programmed death ligand 1 78
Dapagliflozin acutely improvMED/es kidney function in type 2 diabetes mellitus. The PRECARE study 73
A new glucose monitoring system for the intermittent monitoring of interstitial glucose values in patients with diabetes mellitus 72
TIM-3 : a novel regulatory molecule of alloimmune activation 71
Near normalization of metabolic and functional features of the central nervous system in type 1 diabetic patients with end-stage renal disease after kidney-pancreas transplantation 69
Targeting a novel apoptotic pathway in human disease 69
Glucagon-like peptide 1 receptor is a T cell-negative costimulatory molecule 68
Nephrological Indications in Combined Liver-Kidney Transplantation 68
A novel clinically relevant approach to tip the balance toward regulation in stringent transplant model 67
Inflammation and vascular dysfunction: The negative synergistic combination of diabetes and COVID-19 63
Type 1 Diabetes and Dysfunctional Intestinal Homeostasis 63
Nuovi aspetti immunologici del trapianto di rene in eta' pediatrica = Novel immunological aspects of pediatric kidney transplantation 61
Neuroblastoma suppressor of tumorigenicity 1 is a circulating protein associated with progression to end-stage kidney disease in diabetes 59
Novel therapeutic and diagnostic management of heart transplant patients 58
TMEM219 regulates the transcription factor expression and proliferation of beta cells 48
eATP and autoimmune diabetes 46
Reply to letter to the editor regarding “Use of DPP-4 inhibitors in patients with COVID-19” 44
null 37
Daytime hypoglycemic episodes during the use of an advanced hybrid closed loop system 34
Vaccinome landscape in nearly 620 000 patients with diabetes 34
Role of podocyte B7-1 in diabetic nephropathy 20
Is beta2-microglobulin-related amyloidosis of hemodialysis patients a multifactorial disease? A new pathogenetic approach 16
Platelet activation and PDGF-AB release during dialysis 7
In vivo evaluation of cellular and inflammatory response to a new polyethersulfone membrane 7
Totale 15.503
Categoria #
all - tutte 41.275
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.275


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020228 0 0 0 0 0 0 0 0 0 150 35 43
2020/20211.263 42 92 30 36 113 174 146 64 89 190 114 173
2021/20221.619 120 125 77 158 118 140 90 100 165 173 100 253
2022/20233.022 177 221 248 220 239 371 259 255 371 169 281 211
2023/20243.305 231 241 274 294 534 289 181 229 187 224 320 301
2024/20253.638 279 453 272 472 348 308 511 591 399 5 0 0
Totale 15.503